Phase 1 Study of SNDX-5613 in Combination with Intensive Chemotherapy in Participants with AML Harboring Alterations in KMT2A/MLL, NPM1, or NUP98 Genes

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514531-18-00

Acronym

SNDX-5613-0708

Enrollment

Registered

2025-02-03

Start date

2025-05-20

Completion date

Unknown

Last updated

2025-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myeloid Leukemias

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026